HopeStage
Back to all studies
CompletedNCT04286282

Neuroinflammation and Modulating Factors in Depression and HIV

Behavioural studyAges 18–65Uganda
The study in practice

Understand this study

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Listed locations
KampalaSee all locations and recruitment
Study clarity

Study information

Study start dateStarted: February 1, 2021
Recruitment status
Completed
Enrollment listed in the registry
109
Sponsor
University of Minnesota
Sponsor type
University
Study type
Behavioral
Intervention type
Psychotherapy / behavioral intervention, OTHER
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
Uganda
Age range
From 18 Years to 65 Years
Official registry ID
NCT04286282
Official title
Show the full official title

Neuroinflammation and Modulating Factors in Depression and HIV: The Growth Study-Group Therapy in HIV for Depression IN Uganda

Looking for a study you can join?

Explore recruiting studies

Get this study by email

HopeStage may email me about this study.
Loading the security check...

Recruitment & locations

Completed

Kampala

FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of Minnesota, a university.

Who was this study for?

This study was for people with depression. Listed age limits: 18 years to 65 years. Other eligibility criteria applied.

Want to explore more studies?

Explore studies